Find information on thousands of medical conditions and prescription drugs.

Caduet

Caduet is a medication approved by the US FDA for the treatment of high cholesterol and high blood pressure. It is a combination of atorvastatin (Lipitor) and Amlodipine (Norvasc). It is currently being marketed by the pharmaceutical company Pfizer.

A

B

C

Calcium folinate

Chenodeoxycholic acid

Chloramphenicol

Chlordiazepoxide

Chlorprothixene

Chlortetracycline

Choriogonadotropin alfa

Chorionic gonadotropin

Clavulanic acid

Cyclobenzaprine

Cyclophosphamide

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Read more at Wikipedia.org

• [List your site here Free!]



	Caduet Treats Two Cardiovascular Conditions at Once In January 2004, the Food and Drug Administration (FDA) approved the new combination drug, Caduet for the treatment of high blood pressure and high cholesterol. From Nurse Practitioner, 6/1/04 by Wimett, Lynn

	Combination products raise manufacturing challenges: new fixed-dose combination drugs aim to enhance safety and efficacy, while regulators clear a path Combination medical products are hot and becoming hotter. In January, the Food and Drug Administration made headlines by quickly approving a fixed-dose-combination ... From Pharmaceutical Technology, 3/1/05 by Jill Wechsler

	Drug makers rush to fill heart-healthy lifestyle gap For all the people who succumb to heart disease each year--some 927,000 in 2002, according to the American Heart Association. There is still a significant ... From Drug Store News, 1/17/05 by Michael Johnsen

	Pfizer Pfizer recently announced it is conducting a clinical study to evaluate Caduet (amlodipine besylate and atorvastatin calcium) in treating African-Americans ... From Drug Store News, 9/27/04

	Mail order gaining on retail pharmacy market share Although the overall prospects for the pharmaceutical industry are still positive, growth in both dollars and prescriptions dispensed is slowing gradually ... From Drug Store News, 9/27/04 by Michael Johnsen

	Cholesterol market grows as potential switch looms There is plenty happening in the statin space to ensure that class of drug s continued dominance on the druggist shelf--and it all bodes well for the ... From Drug Store News, 8/23/04 by Michael Johnsen

	Hypertension and High Cholesterol The U.S. Food and Drug Administration (FDA) approved Pfizer's dualtherapy Caduet [amlodipine besylate (Norvasc)/atorvastatin calcium (Lipitor)] for the ... From Nurse Practitioner, 4/1/04

	Strong Rx pipeline, surge in demand should buy market in '04, IMS reports WASHINGTON -- The U.S. wholesale prescription market rose a solid 11.5 percent to $216.4 billion last year, driven in large part by generic and biotech ... From Drug Store News, 4/5/04 by Bernadette Casey

Home

Contact

Resources

ebay